Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Interest Coverage Ratio (2016)

Historic Interest Coverage Ratio for Heron Therapeutics (HRTX) over the last 3 years, with Q4 2016 value amounting to 63.56.

  • Heron Therapeutics' Interest Coverage Ratio changed N/A to 63.56 in Q4 2016 from the same period last year, while for Sep 2017 it was 128.27, marking a year-over-year change of. This contributed to the annual value of 1.91 for FY2024, which is 9331.71% up from last year.
  • According to the latest figures from Q4 2016, Heron Therapeutics' Interest Coverage Ratio is 63.56.
  • Heron Therapeutics' 5-year Interest Coverage Ratio high stood at 23.61 for Q1 2012, and its period low was 74.19 during Q2 2013.
  • In the last 3 years, Heron Therapeutics' Interest Coverage Ratio had a median value of 63.44 in 2013 and averaged 57.08.
  • The largest annual percentage gain for Heron Therapeutics' Interest Coverage Ratio in the last 5 years was 16872.39% (2013), contrasted with its biggest fall of 16872.39% (2013).
  • Over the past 3 years, Heron Therapeutics' Interest Coverage Ratio (Quarter) stood at 23.61 in 2012, then tumbled by 156.65% to 60.59 in 2013, then fell by 4.89% to 63.56 in 2016.
  • Its last three reported values are 63.56 in Q4 2016, 60.59 for Q3 2013, and 74.19 during Q2 2013.